Clastogenic activity of FK973, a new antitumor agent
β Scribed by Y. Miyamae; O. Hirai; K. Ohara; M. Hashimoto; A. Tensho
- Book ID
- 113251557
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 78 KB
- Volume
- 203
- Category
- Article
- ISSN
- 0165-1161
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
BMY-28175 is a novel antitumor antibiotic produced in fermentation by Actinomadura verrucosospora. The cytotoxic effects of BMY-28175 were determined using murine and human tumor cell lines in vitro. Following 72 hour exposure, the drug had IC50 values 1.5 to 13.5 ng/ml in a microtiter assay. BMY-28
Tiazofurin is an interesting drug now entering Phase I trials, with marked preclinical antitumor activity against P388 and L1210 leukemias, and the Lewis lung carcinoma. Schedule dependency favoring frequent administration has been noted. The drug has a novel mechanism of action, being metabolized